Centene Corporation: Medicaid Managed Care Expansion and Optimization!

Centene Corporation’s recent performance exhibited both strengths and areas for careful attention. The company’s financial results for the fourth quarter of 2024 demonstrated solid earnings power, with adjusted diluted earnings per share (EPS) of $0.80 and a full-year EPS of $7.17. This growth is attributed to robust performance across its business lines, including Medicare and Medicaid, and significant operational improvements. A noteworthy development was the better-than-anticipated results from the Medicare annual enrollment period, coupled with a Medicaid program expansion, prompting Centene to increase its 2025 revenue guidance by $4 billion.